Additional file 2: of Germline breast cancer susceptibility gene mutations and breast cancer outcomes

Table S2. Effects of BRCA germline mutation and other prognostic factors (all covariates) on clinical end points by Cox proportional hazards analysis. The four clinical end points are: breast cancer (BC) recurrence or death, BC recurrence (locoregional or distant), distant recurrence, and death from any cause. Both univariate and multivariate analyses are shown. Statistically significant P-values (<â 0.05) in the multivariate analyses are shown in bold. (XLSX 14 kb)